BSX and AMMD Confront Transvaginal Mesh Lawsuit BSX and AMMD Confront Transvaginal Mesh Lawsuit

Two manufacturers, Boston Scientific Corp. and American Medical Systems Holdings Inc., are at the center of a lawsuit, which alleges the companies sold defective transvaginal mesh products, causing severe harm to a patient. In a complaint filed against Boston Scientific Corp. (NYSE: BSX) and American Medical Systems Holdings Inc. (NSDQ: AMMD), a patient is alleging mesh… Read More

Contaminated Avastin Causing Blindness New York Times: Contaminated Avastin Causing Blindness

New York Times: Five veterans in Los Angeles were blinded after receiving Avastin to treat eye disease, prompting an investigation by the Department of Veterans Affairs. To date, at least 21 patients have suffered eye infection or blindness after being injected with Avastin. In a September 1, 2011 article, the New York Times reported five… Read More

DMAA Not Derived from Geranium AHPA: DMAA Not Derived from Geranium

American Herbal Products Association board: Dietary supplement ingredient DMAA (also known as 1,3-dimethylamylamine) may no longer be labeled as geranium oil, after a review of scientific literature determined there was no credible evidence DMAA is found in geraniums. DMAA was initially introduced by Eli Lilly and Company in 1971 as an inhaled nasal-decongestant called Forthane. More… Read More

Reclast Kidney Failure Lawsuits Reclast Kidney Failure Lawsuits

September 1, 2011 — The FDA has recently released a Drug Safety Communication notifying the public about an update to the drug label of Reclast (generic: zoledronic acid), the osteoporosis medication administered through injection. Reclast has been linked to higher risks of kidney failure, which have required dialysis or even caused death. What You Can… Read More

Saphris Lawsuits Saphris Lawsuits

September 1, 2011 — The FDA recently linked the antipsychotic medication Saphris (generic: asenapine maleate) to increased risks of serious allergic reactions, including anaphylaxis, which may be life-threatening or require hospitalization. What You Can Do & How We Can Help The Schmidt Firm, LLP is currently accepting Saphris induced injury cases in all 50 states…. Read More

Industry Plans Campaign Against Transvaginal Mesh Recall Industry Plans Campaign Against Transvaginal Mesh Recall

MedCity article: The transvaginal mesh industry is preparing a major counter campaign against the FDA and Public Citizen. While the FDA and public interest group Public Citizen are calling for increased regulation and even the recall of transvaginal mesh products, the industry — led by lobbyist and trade group AdvaMed — is preparing its own… Read More

FDA Convenes Committee to Discuss Safety of Transvaginal Mesh FDA Convenes Committee to Discuss Safety of Transvaginal Mesh

September 2011 — The FDA has asked a public advisory committee to convene September 8-9, in order to discuss and make recommendations regarding the safety and effectiveness of transvaginal surgical mesh for repair of pelvic organ prolapse (POP) and stress urinary incontinence (SUI). More than likely, the meeting will probably be the deciding factor if… Read More

Transvaginal Mesh Poses Greater Risks than Other Procedures Transvaginal Mesh Poses Greater Risks than Other Procedures

FDA News Release — The FDA issued an updated safety communication on July 13, 2011 warning doctors and patients that surgical vaginal mesh repair of pelvic organ prolapse (POP) may expose patients to greater risks than other repair procedures. After reviewing scientific data published between 1996 and 2010 comparing vaginal mesh surgeries to other forms… Read More

FDA Releases Safety Communication with Updated Transvaginal Mesh Complications FDA Releases Safety Communication with Updated Transvaginal Mesh Complications

July 13, 2011 — The FDA released a Safety Communication in order to update doctors and patients about serious complications associated with transvaginal placement of surgical mesh. While an initial Public Health Notification warned of health complications in 2008, the FDA is updating its information to include the fact that the serious risks of transvaginal… Read More

FDA Updates Warning Against Transvagional Mesh FDA Updates Warning Against Transvaginal Mesh

July 2011 — In October 2008, The FDA issued a Public Health Notification to notify patients and doctors about the adverse side effects associated with transvaginal mesh implantation to repair pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Almost three years later, the FDA has recently published an update to its 2008 findings. The… Read More

«1…11121314151617…38»